ConductScience.org, home

Paper42985516PubMed

Antigen-specific regulatory cell therapy approaches in kidney transplantation.

Tripathi S and 1 other. Front Immunol, 2026.

Cite this record

ConductScience Library. Antigen-specific regulatory cell therapy approaches in kidney transplantation. Papers, record 42985516. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42985516

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antigen-specific regulatory cell therapy approaches in kidney transplantation.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-06

Source PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tripathi SSudipta
2Chandraker AAnil

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Kidney TransplantationMajor topic
T-Lymphocytes, RegulatoryMajor topic
Graft RejectionMajor topic
Immunotherapy, AdoptiveMajor topic
Humans
Animals
Transplantation Tolerance
Isoantigens
Graft Survival

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133519807The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities.Front Immunol2020https://conductscience.org/library/papers/33519807PubMed
235694562Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation.Kidney Int Rep2022https://conductscience.org/library/papers/35694562PubMed
322167587Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.Nephrol Dial Transplant2012https://conductscience.org/library/papers/22167587PubMed
429552576A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials.Mol Ther Methods Clin Dev2018https://conductscience.org/library/papers/29552576PubMed
533087345Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.BMJ2020https://conductscience.org/library/papers/33087345PubMed
642358982CD25+CD27+CD70- alloantigen-specific Tregs: promising stable immunotherapy for transplantation.Front Immunol2026https://conductscience.org/library/papers/42358982PubMed
739824564Optimizing protocols for human regulatory T isolation, expansion, and characterization.Methods Cell Biol2025https://conductscience.org/library/papers/39824564PubMed
835371066Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant.Front Immunol2022https://conductscience.org/library/papers/35371066PubMed
926773713A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.Hepatology2016https://conductscience.org/library/papers/26773713PubMed
1027693388Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions.Exp Hematol2017https://conductscience.org/library/papers/27693388PubMed
1122566933Molecular mechanisms of treg-mediated T cell suppression.Front Immunol2012https://conductscience.org/library/papers/22566933PubMed
1237422112Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial.Am J Transplant2023https://conductscience.org/library/papers/37422112PubMed
1330429370Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.JCI Insight2018https://conductscience.org/library/papers/30429370PubMed
1436972454Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/36972454PubMed
1535434896Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.Am J Transplant2022https://conductscience.org/library/papers/35434896PubMed
1640740779Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy.Front Immunol2025https://conductscience.org/library/papers/40740779PubMed
1729743501A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.Sci Rep2018https://conductscience.org/library/papers/29743501PubMed
1831811270Treg cell-based therapies: challenges and perspectives.Nat Rev Immunol2020https://conductscience.org/library/papers/31811270PubMed
1934705520Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.Sci Transl Med2021https://conductscience.org/library/papers/34705520PubMed
2041246323Regulatory T cell therapies: from patient data to biological insights.Front Immunol2025https://conductscience.org/library/papers/41246323PubMed

See all 54 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42985516

GET https://conductscience.org/api/papers/v1/42985516/references?page=2